GB2325408B - Chewing gum formulation comprising ondansetron - Google Patents

Chewing gum formulation comprising ondansetron

Info

Publication number
GB2325408B
GB2325408B GB9816045A GB9816045A GB2325408B GB 2325408 B GB2325408 B GB 2325408B GB 9816045 A GB9816045 A GB 9816045A GB 9816045 A GB9816045 A GB 9816045A GB 2325408 B GB2325408 B GB 2325408B
Authority
GB
United Kingdom
Prior art keywords
ondansetron
chewing gum
gum formulation
formulation
chewing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9816045A
Other versions
GB9816045D0 (en
GB2325408A (en
Inventor
Kenneth Francis Prendergast
Trevor Henry Redpath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB9816045A priority Critical patent/GB2325408B/en
Publication of GB9816045D0 publication Critical patent/GB9816045D0/en
Publication of GB2325408A publication Critical patent/GB2325408A/en
Application granted granted Critical
Publication of GB2325408B publication Critical patent/GB2325408B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB9816045A 1994-06-28 1994-06-28 Chewing gum formulation comprising ondansetron Expired - Fee Related GB2325408B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9816045A GB2325408B (en) 1994-06-28 1994-06-28 Chewing gum formulation comprising ondansetron

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9412950A GB2290963A (en) 1994-06-28 1994-06-28 Pharmaceutical uses of ondansetron
GB9816045A GB2325408B (en) 1994-06-28 1994-06-28 Chewing gum formulation comprising ondansetron

Publications (3)

Publication Number Publication Date
GB9816045D0 GB9816045D0 (en) 1998-09-23
GB2325408A GB2325408A (en) 1998-11-25
GB2325408B true GB2325408B (en) 1999-01-27

Family

ID=10757437

Family Applications (4)

Application Number Title Priority Date Filing Date
GB9816045A Expired - Fee Related GB2325408B (en) 1994-06-28 1994-06-28 Chewing gum formulation comprising ondansetron
GB9822734A Withdrawn GB2327348A (en) 1994-06-28 1994-06-28 Pharmaceutical use of ondansetron
GB9412950A Withdrawn GB2290963A (en) 1994-06-28 1994-06-28 Pharmaceutical uses of ondansetron
GB9816046A Expired - Fee Related GB2325409B (en) 1994-06-28 1994-06-28 Pharmaceutical use of ondansetron/cyclodextrin complexes

Family Applications After (3)

Application Number Title Priority Date Filing Date
GB9822734A Withdrawn GB2327348A (en) 1994-06-28 1994-06-28 Pharmaceutical use of ondansetron
GB9412950A Withdrawn GB2290963A (en) 1994-06-28 1994-06-28 Pharmaceutical uses of ondansetron
GB9816046A Expired - Fee Related GB2325409B (en) 1994-06-28 1994-06-28 Pharmaceutical use of ondansetron/cyclodextrin complexes

Country Status (1)

Country Link
GB (4) GB2325408B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
DE102010024050B4 (en) 2010-06-16 2014-12-31 Magna Car Top Systems Gmbh Moving roof for a passenger car
CN103919052A (en) * 2014-01-21 2014-07-16 中国人民解放军第三军医大学 Composition used for physical recovery, and its application
EP3589369A4 (en) 2017-01-09 2020-03-18 DAS-MG, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2153821A (en) * 1984-01-25 1985-08-29 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2153821A (en) * 1984-01-25 1985-08-29 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives

Also Published As

Publication number Publication date
GB9816045D0 (en) 1998-09-23
GB2290963A (en) 1996-01-17
GB2325409B (en) 1999-02-10
GB9412950D0 (en) 1994-10-26
GB2325408A (en) 1998-11-25
GB9816046D0 (en) 1998-09-23
GB9822734D0 (en) 1998-12-16
GB2327348A (en) 1999-01-27
GB2325409A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
GR3033556T3 (en) Non-stick chewing gum
EG24077A (en) Oral 2-methyl-thieno-benzodiazepine formulation
PL319604A1 (en) Fruit-juice filled chewing gum
FI954867A (en) Chewing gum
AU5510398A (en) Crunchy chewing gum
PL333101A1 (en) Chewing gum containing colloidal basic bismuth citrate
ZA957980B (en) Oral compositions
AU8055394A (en) Chewing gum
EP0725567A4 (en) Improved chewing gum compositions and methods for manufacturing same
NZ300435A (en) Oral compositions comprising an aminoalkylsilicone
EP0472428A3 (en) Low moisture chewing gum
ZA955519B (en) Oral compositions
PL320866A1 (en) Oral compositions
EP0758850A4 (en) Improved sugarless non-tack chewing gum
EP0907325A4 (en) Chewing gum containing gum talha
EP0793421A4 (en) Improved chewing gum containing salatrim
GB2325408B (en) Chewing gum formulation comprising ondansetron
GB9425933D0 (en) Oral compositions
EP1032276A4 (en) Chewing gum containing trehalose
EP0575977A3 (en) Chewing gum compositions.
AU1086495A (en) Improved chewing gum containing caprenin
GB9907207D0 (en) Tooth 'n' gum chewing gum
GB9700412D0 (en) Chewing gum
GB9513690D0 (en) Chewing gum
GB2292886B (en) Oral hygiene formulation

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20000628